Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FH216
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,596
Award facts
- Contract value 100% obligated
- $31,596.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,596.13 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 7, 2025, under a firm fixed-price contract type with an ultimate completion date of December 8, 2025. This non-set-aside award was made competitively and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, will fulfill pharmaceutical and medical supply requirements in support of federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's prime IDC with the DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The prime indefinite delivery vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs and other federal customers such as the Defense Health Agency and U.S. Coast Guard. The DLA's strategic approach involves establishing multiple regional contracts under its Pharmaceutical Prime Vendor Global Program Generation V initiative, positioning AmerisourceBergen to serve as a critical supplier within this competitive procurement framework.
Quick answers
Who was awarded contract SPE2DU26FH216?
SPE2DU26FH216 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 7, 2025.
How much is contract SPE2DU26FH216 worth?
The government has obligated $31,596 on SPE2DU26FH216.
Is contract SPE2DU26FH216 an order under another contract?
Yes. SPE2DU26FH216 is a delivery order under SPE2DU25D4116, an indefinite delivery contract.
Was contract SPE2DU26FH216 competed?
The extent of competition for SPE2DU26FH216 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award